Next, the disruption of the FAK scaffold activity for endophilin A2 decreased the surface expression of MT1-MMP and the expression of EMT-driver markers, thus suppressing the metastatic phenotype in a murine model of human breast cancer [120]. This evidence concerns the gene PTK2 and breast carcinoma.